Helmut R. Maëcke

14.1k total citations
173 papers, 11.0k citations indexed

About

Helmut R. Maëcke is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Helmut R. Maëcke has authored 173 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Epidemiology, 102 papers in Radiology, Nuclear Medicine and Imaging and 91 papers in Oncology. Recurrent topics in Helmut R. Maëcke's work include Neuroendocrine Tumor Research Advances (103 papers), Radiopharmaceutical Chemistry and Applications (96 papers) and Lung Cancer Research Studies (58 papers). Helmut R. Maëcke is often cited by papers focused on Neuroendocrine Tumor Research Advances (103 papers), Radiopharmaceutical Chemistry and Applications (96 papers) and Lung Cancer Research Studies (58 papers). Helmut R. Maëcke collaborates with scholars based in Switzerland, Germany and United States. Helmut R. Maëcke's co-authors include Jean Claude Reubi, Melpomeni Fani, Jan Mueller‐Brand, Beatrice Waser, Flavio Forrer, Christian Waldherr, A. Heppeler, João Paulo André, Wolfgang Weber and Hanwen Zhang and has published in prestigious journals such as Journal of the American Chemical Society, Gastroenterology and PLoS ONE.

In The Last Decade

Helmut R. Maëcke

171 papers receiving 10.7k citations

Peers

Countries citing papers authored by Helmut R. Maëcke

Since Specialization

Citations

This map shows the geographic impact of Helmut R. Maëcke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helmut R. Maëcke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helmut R. Maëcke more than expected).

Fields of papers citing papers by Helmut R. Maëcke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helmut R. Maëcke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helmut R. Maëcke. The network helps show where Helmut R. Maëcke may publish in the future.

Co-authorship network of co-authors of Helmut R. Maëcke

This figure shows the co-authorship network connecting the top 25 collaborators of Helmut R. Maëcke. A scholar is included among the top collaborators of Helmut R. Maëcke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helmut R. Maëcke. Helmut R. Maëcke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm? 2023 ·International Journal of Molecular Sciences ·Leszek Królicki, Jolanta Kunikowska, Dominik Cordier, Nedelina Slavova, Henryk Koziara, Frank Bruchertseifer, Helmut R. Maëcke, Alfred Morgenstern, Adrian Merlo	3
2	Radioiodinated Exendin-4 Is Superior to the Radiometal-Labelled Glucagon-Like Peptide-1 Receptor Probes Overcoming Their High Kidney Uptake 2017 ·PLoS ONE ·Tilman Läppchen, (unknown), Jos Eersels, Philipp T. Meyer, Helmut R. Maëcke, Svetlana N. Rylova	24
3	Approaches to Improve the Pharmacokinetics of Radiolabeled Glucagon-Like Peptide-1 Receptor Ligands Using Antagonistic Tracers 2016 ·Journal of Nuclear Medicine ·Svetlana N. Rylova, Beatrice Waser, Luigi Del Pozzo, (unknown), Rosalba Mansi, Philipp T. Meyer, Jean Claude Reubi, Helmut R. Maëcke	20
4	Radiopharmaceuticals for somatostatin receptor imaging 2016 ·Nuclear Medicine Review ·Renata Mikołajczak, Helmut R. Maëcke	34
5	(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors 2015 ·PLoS ONE ·Eleni Gourni, (unknown), Victor Gonçalves, Franck Denat, Philipp T. Meyer, Helmut R. Maëcke	52
6	Positron Emission Tomography (PET) Imaging of Prostate Cancer with a Gastrin Releasing Peptide Receptor Antagonist - from Mice to Men 2014 ·Theranostics ·Gesche Wieser, Rosalba Mansi, Anca-Ligia Grosu, Wolfgang Schultze‐Seemann, Rebecca A. Dumont, Philipp T. Meyer, Helmut R. Maëcke, Jean Claude Reubi, Wolfgang Weber	123
7	Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study 2013 ·Journal of Translational Medicine ·Nicolas Marincek, (unknown), Philippe Brunner, Christian Schindler, Michael Koller, Christoph Rochlitz, Jan Müller‐Brand, Helmut R. Maëcke, Matthias Briel, Martin A. Walter	21
8	Is there need for radioimmunotherapy? results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximab. 2012 ·PubMed ·Flavio Forrer, (unknown), Benedetta Campana, Helmut R. Maëcke, (unknown), Andreas Lohri	7
9	Glucagon-like peptide 1 receptor (GLP-1R) imaging for the preoperative localization of benign insulinomas in 30 patients 2012 ·15th International & 14th European Congress of Endocrinology ·Emanuel Christ, Flavio Forrer, Damian Wild, Thomas Clerici, (unknown), Helmut R. Maëcke, P. J. Ell, M. Caplin, Beat Gloor, Jean Claude Reubi	2
10	Biokinetics and dosimetry of 111In-DOTA-NOC-ATE compared with 111In-DTPA-octreotide 2012 ·European Journal of Nuclear Medicine and Molecular Imaging ·Ariane Boubaker, John O. Prior, Jean‐Pierre Willi, (unknown), Marek Kosinski, Angelika Bischof Delaloye, Helmut R. Maëcke, Mihaela Ginj, Sébastien Baechler, Franz Buchegger	5
11	Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN) 2011 ·Cancer Research ·Damian Wild, (unknown), Hanwen Zhang, Aliyah Morgenstern, Frank Bruchertseifer, Julie Boisclair, (unknown), Jean–Claude Reubi, Helmut R. Maëcke	105
12	Imaging Expression of the Human Somatostatin Receptor Subtype-2 Reporter Gene with ⁶⁸Ga-DOTATOC 2010 ·Journal of Nuclear Medicine ·Hanwen Zhang, Maxim A. Moroz, Inna Serganova, Thomas W. Ku, Ruimin Huang, Jelena Vider, Helmut R. Maëcke, Steven M. Larson, Ronald G. Blasberg, Peter Smith‐Jones	59
13	Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid–Conjugated Bombesin-Based Radioantagonist for the Labeling with Single-Photon Emission Computed Tomography, Positron Emission Tomography, and Therapeutic Radionuclides 2009 ·Clinical Cancer Research ·Rosalba Mansi, Xuejuan Wang, Flavio Forrer, Stefan Kneifel, Maria‐Luisa Tamma, Beatrice Waser, Renzo Cescato, Jean Claude Reubi, Helmut R. Maëcke	147
14	Role of Free Fatty Acids in Regulating Gastric Emptying and Gallbladder Contraction 2006 ·Digestion ·Lukas Degen, Daniel Matzinger, Jürgen Drewe, (unknown), Helmut R. Maëcke, Hans Lengsfeld, Paul Hadváry, Christoph Beglinger	24
15	Synthesis of HYNIC- and DOTA-Conjugates with mi-Opioid Receptor Ligands: Morphiceptin and Endomorphin-2 2004 ·Polish Journal of Chemistry ·Jakub Fichna, Anna Janecka, Piotr Kossoń, Helmut R. Maëcke	3
16	Efficacy of ^99m Tc-EDDA/HYNIC-TOC Scintigraphy in Differential Diagnosis of Solitary Pulmonary Nodules 2004 ·Cancer Biotherapy and Radiopharmaceuticals ·Anna Płachcińska, Renata Mikołajczak, Helmut R. Maëcke, Józef Kozak, (unknown), (unknown), Jacek Kuśmierek	8
17	Targeted radiotherapy for small cell lung cancer using 90Yttrium-DOTATOC, an Yttrium-labelled somatostatin analogue: a pilot trial 2004 ·Lung Cancer ·Miklos Pless, Christian Waldherr, Helmut R. Maëcke, Carlos Buitrago, Richard Herrmann, Jan Mueller‐Brand	28
18	Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC. 2002 ·PubMed ·Christian Waldherr, Miklos Pless, Helmut R. Maëcke, Tilmann Schumacher, (unknown), Egbert Nitzsche, Andreas Haldemann, Jan Mueller‐Brand	374
19	DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy 1997 ·European Journal of Nuclear Medicine and Molecular Imaging ·Andreas Otte, E. Jermann, Martin Béhé, (unknown), Heiner C. Bucher, H.W. Roser, A. Heppeler, Jan Mueller‐Brand, Helmut R. Maëcke	171
20	Synthesis and evaluation of two new bifunctional carboxymethylated tetraazamacrocyclic chelating agents for protein labeling with indium-111 1990 ·Bioconjugate Chemistry ·(unknown), (unknown), Helmut R. Maëcke	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact